Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Author(s) -
Gabriella Captur,
James Moon,
ConstantinCristian Topriceanu,
George Joy,
Leo Swadling,
Jenny Hällqvist,
Ivan Doykov,
Nina Patel,
Justyna Śpiewak,
Tomas Baldwin,
Matt Hamblin,
Katia Menacho,
Marianna Fontana,
Thomas A. Treibel,
Charlotte Manisty,
Benjamin O’Brien,
Joseph M. Gibbons,
Corrina Pade,
Tim Brooks,
Daniel M. Altmann,
Rosemary J. Boyton,
Áine McKnight,
Mala K. Maini,
Mahdad Noursadeghi,
Kevin Mills,
Wendy Heywood
Publication year - 2022
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2022.104293
Subject(s) - medicine , asymptomatic , interquartile range , seroconversion , cohort , subclinical infection , immunology , antibody , proteome , young adult , cohort study , bioinformatics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom